Renda Bower knows well the cost of drugs to treat rheumatoid arthritis – her husband, son and daughter all have the painful, disabling autoimmune disease. And the family’s finances revolve around paying for them

Quick Read

When the government says a new drug is approved for sale, the first thing many companies do is announce what it will cost. Not Spark Therapeutics, though

Quick Read

Researchers at the University of Maryland School of Medicine were shocked to find that nearly half of all medical care in the United States is delivered at hospital emergency departments

Quick Read

Who will pay for it? And how?

Quick Read

The drug, Mavyret, is the first to be approved by the Food and Drug Administration that can cure all six genetic types of hepatitis C in about two months in patients who haven’t previously been treated. Other approved drugs generally require 12 weeks to treat the disease and often aren’t effective for all types of hepatitis C

Quick Read

Judith Garber and Shannon Brownlee: While the top-ranked hospitals were patting themselves on the back, we wondered if the magazine’s ranking system actually measures what matters to patients, or for that matter to anybody who is worried about the cost and quality of US health care. So we took a closer look at how U.S. News measures hospital quality and—just as important—what factors its analysis leaves out

Quick Read

Over Humira’s lifetime, AbbVie has secured more than 100 patents to prevent anyone from attempting to copy the biologic, with $16 billion in annual sales

Quick Read

When doctors talk about a new leukemia drug from Novartis, they ooze enthusiasm, using words like “breakthrough,” “revolutionary” and “a watershed moment.” But when they think about how much the therapy is likely to cost, their tone turns alarmist. “It’s going to cost a fortune,” said Dr. Ivan Borrello at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore

Quick Read